{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T07:57:20Z","timestamp":1648627040416},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,2,20]],"date-time":"2009-02-20T00:00:00Z","timestamp":1235088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00108-008-2250-5","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T15:11:24Z","timestamp":1234969884000},"page":"276-290","source":"Crossref","is-referenced-by-count":4,"title":["Autoimmune Thrombozytopenie, Neutropenie und H\u00e4molyse"],"prefix":"10.1007","volume":"50","author":[{"given":"A.","family":"Greinacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,20]]},"reference":[{"key":"2250_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/10245330701383908","volume":"12","author":"Aledort","year":"2007","unstructured":"Aledort LM, Salama A, Kovaleva L et al (2007) Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura. Hematology 12: 289\u2013295","journal-title":"Hematology"},{"key":"2250_CR2","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.seminhematol.2007.11.003","volume":"44","author":"Arnold","year":"2007","unstructured":"Arnold DM, Kelton JG (2007) Current options for the treatment of idiopathic thrombocytopenic purpura. Semin Hematol 44: S12\u2013S23","journal-title":"Semin Hematol"},{"key":"2250_CR3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V71.4.1165.1165","volume":"71","author":"Bellucci","year":"1988","unstructured":"Bellucci S, Charpak Y, Chastang C, Tobelem G (1988) Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults. Blood 71: 1165\u20131169","journal-title":"Blood"},{"key":"2250_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000204251","volume":"91","author":"Ben","year":"1994","unstructured":"Ben Yehuda D, Gillis S, Eldor A (1994) Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol 91: 1\u20136","journal-title":"Acta Haematol"},{"key":"2250_CR5","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood.V74.7.2309.2309","volume":"74","author":"Berchtold","year":"1989","unstructured":"Berchtold P, McMillan R (1989) Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 74: 2309\u20132317","journal-title":"Blood"},{"key":"2250_CR6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jinf.2001.0904","volume":"43","author":"Bisharat","year":"2001","unstructured":"Bisharat N, Omari H, Lavi I, Raz R (2001) Risk of infection and death among post-splenectomy patients. J Infect 43: 182\u2013186","journal-title":"J Infect"},{"key":"2250_CR7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)92205-5","volume":"344","author":"Blanchette","year":"1994","unstructured":"Blanchette V, Imbach P, Andrew M et al (1994) Randomised trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344: 703\u2013707","journal-title":"Lancet"},{"key":"2250_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02343213","volume":"146","author":"Buchanan","year":"1987","unstructured":"Buchanan GR (1987) The nontreatment of childhood idiopathic thrombocytopenic purpura. Eur J Pediatr 146: 107\u2013112","journal-title":"Eur J Pediatr"},{"key":"2250_CR9","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","volume":"357","author":"Bussel","year":"2007","unstructured":"Bussel JB, Cheng G, Saleh MN et al (2007) Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 357: 2237\u20132247","journal-title":"N Engl J Med"},{"key":"2250_CR10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa054626","volume":"355","author":"Bussel","year":"2006","unstructured":"Bussel JB, Kuter DJ, George JN et al. (2006) AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 355: 1672\u20131681","journal-title":"N Engl J Med"},{"key":"2250_CR11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1537-2995.1999.39060662.x","volume":"39","author":"Bux","year":"1999","unstructured":"Bux J (1999) Nomenclature of granulocyte alloantigens. ISBT working party on Platelet and Granulocyte Serology, Granulocyte Antigen working party. International Society of Blood Transfusion. Transfusion 39: 662\u2013663","journal-title":"Transfusion"},{"key":"2250_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V91.1.181","volume":"91","author":"Bux","year":"1998","unstructured":"Bux J, Behrens G, Jaeger G, Welte K (1998) Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 91: 181\u2013186","journal-title":"Blood"},{"key":"2250_CR13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1537-2995.1997.37997454028.x","volume":"37","author":"Bux","year":"1997","unstructured":"Bux J, Chapman J (1997) Report on the second international granulocyte serology workshop. Transfusion 37: 977\u2013983","journal-title":"Transfusion"},{"key":"2250_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01698373","volume":"63","author":"Bux","year":"1991","unstructured":"Bux J, Kissel K, Nowak K et al (1991) Autoimmune neutropenia: clinical and laboratory studies in 143 patients. Ann Hematol 63: 249\u2013252","journal-title":"Ann Hematol"},{"key":"2250_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2141.1992.tb04588.x","volume":"82","author":"Bux","year":"1992","unstructured":"Bux J, Sohn M, Hachmann R, Mueller-Eckhardt C (1992) Quantitation of granulocyte antibodies in sera and determination of their binding sites. Br J Haematol 82: 20\u201325","journal-title":"Br J Haematol"},{"key":"2250_CR16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","volume":"346","author":"Cines","year":"2002","unstructured":"Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346: 995\u20131008","journal-title":"N Engl J Med"},{"key":"2250_CR17","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","volume":"160","author":"Cohen","year":"2000","unstructured":"Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B (2000) The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 160: 1630\u20131638","journal-title":"Arch Intern Med"},{"key":"2250_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07054.x","volume":"141","author":"Garvey","year":"2008","unstructured":"Garvey B (2008) Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 141: 149\u2013169","journal-title":"Br J Haematol"},{"key":"2250_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","volume":"359","author":"Godeau","year":"2002","unstructured":"Godeau B, Chevret S, Varet B et al (2002) Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 359: 23\u201329","journal-title":"Lancet"},{"key":"2250_CR20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2008-01-131029","volume":"112","author":"Godeau","year":"2008","unstructured":"Godeau B, Porcher R, Fain O et al (2008) Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood 112: 999\u20131004","journal-title":"Blood"},{"key":"2250_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1423-0410.1990.tb05000.x","volume":"58","author":"Gottsche","year":"1990","unstructured":"Gottsche B, Salama A, Mueller-Eckhardt C (1990) Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang 58: 281\u2013286","journal-title":"Vox Sang"},{"key":"2250_CR22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood.V84.2.625.625","volume":"84","author":"Hartman","year":"1994","unstructured":"Hartman KR, LaRussa VF, Rothwell SW et al (1994) Antibodies to myeloid precursor cells in autoimmune neutropenia. Blood 84: 625\u2013631","journal-title":"Blood"},{"key":"2250_CR23","doi-asserted-by":"crossref","first-page":"81a","DOI":"10.1182\/blood.V110.11.81.81","volume":"110","author":"Kantarjian","year":"2007","unstructured":"Kantarjian HM, Fenaux P, Sekeres MA et al (2007) Phase 1\/2 study of AMG 531 in thrombocytopenic patients with low-risk myelodysplastic syndrome: update including extended treatment. Blood 110: 81a (abstract)","journal-title":"Blood"},{"key":"2250_CR24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1991.tb08592.x","volume":"77","author":"Klaassen","year":"1991","unstructured":"Klaassen RJ, Vlekke AB, dem Borne AE (1991) Neutrophil-bound immunoglobulin in HIV infection is of autoantibody nature. Br J Haematol 77: 403\u2013409","journal-title":"Br J Haematol"},{"key":"2250_CR25","first-page":"559","volume":"18","author":"Klumpp","year":"1996","unstructured":"Klumpp TR, Herman JH, Schnell MK et al (1996) Association between antibodies reactive with neutrophils, rate of neutrophil engraftment and incidence of post-engraftment neutropenia following BMT. Bone Marrow Transplant 18: 559\u2013564","journal-title":"Bone Marrow Transplant"},{"key":"2250_CR26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00043426-200307000-00011","volume":"25","author":"Kobayashi","year":"2003","unstructured":"Kobayashi M, Sato T, Kawaguchi H et al (2003) Efficacy of prophylactic use of trimethoprim-sulfamethoxazole in autoimmune neutropenia in infancy. J Pediatr Hematol Oncol 25: 553\u2013557","journal-title":"J Pediatr Hematol Oncol"},{"key":"2250_CR27","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","volume":"104","author":"Kojouri","year":"2004","unstructured":"Kojouri K, Vesely SK, Terrell DR, George JN (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response and surgical complications. Blood 104: 2623\u20132634","journal-title":"Blood"},{"key":"2250_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2249.2000.01195.x","volume":"120","author":"Kurien","year":"2000","unstructured":"Kurien BT, Newland J, Paczkowski C et al (2000) Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol 120: 209\u2013217","journal-title":"Clin Exp Immunol"},{"key":"2250_CR29","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2006-10-019315","volume":"109","author":"Kuter","year":"2007","unstructured":"Kuter DJ (2007) New thrombopoietic growth factors. Blood 109: 4607\u20134616","journal-title":"Blood"},{"key":"2250_CR30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","volume":"371","author":"Kuter","year":"2008","unstructured":"Kuter DJ, Bussel JB, Lyons RM et al (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 371: 395\u2013403","journal-title":"Lancet"},{"key":"2250_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0042-9007.2003.00374.x","volume":"85","author":"Kwon","year":"2003","unstructured":"Kwon SW, Procter J, Dale JK et al. (2003) Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome. Vox Sang 85: 307\u2013312","journal-title":"Vox Sang"},{"key":"2250_CR32","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood.V86.9.3553.bloodjournal8693553","volume":"86","author":"Lamour","year":"1995","unstructured":"Lamour A, Le Corre R, Pennec YL et al (1995) Heterogeneity of neutrophil antibodies in patients with primary Sjogren\u2019s syndrome. Blood 86: 3553\u20133559","journal-title":"Blood"},{"key":"2250_CR33","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/j.1537-2995.2008.01805.x","volume":"48","author":"Mayer","year":"2008","unstructured":"Mayer B, Yurek S, Kiesewetter H, Salama A (2008) Mixed-type autoimmune hemolytic anemia: differential diagnosis and a critical review of reported cases. Transfusion 48: 2229\u20132234","journal-title":"Transfusion"},{"key":"2250_CR34","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminhematol.2007.11.002","volume":"44","author":"McMillan","year":"2007","unstructured":"McMillan R (2007) The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol 44: S3\u2013S11","journal-title":"Semin Hematol"},{"key":"2250_CR35","first-page":"323","volume":"13","author":"Murphy","year":"1976","unstructured":"Murphy S, LoBuglio AF (1976) Drug therapy of autoimmune hemolytic anemia. Semin Hematol 13: 323\u2013334","journal-title":"Semin Hematol"},{"key":"2250_CR36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00277-002-0488-x","volume":"81","author":"Pamuk","year":"2002","unstructured":"Pamuk GE, Pamuk ON, Baslar Z et al (2002) Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Ann Hematol 81: 436\u2013440","journal-title":"Ann Hematol"},{"key":"2250_CR37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.1982.tb02801.x","volume":"51","author":"Pegels","year":"1982","unstructured":"Pegels JG, Helmerhorst FM, van Leeuwen EF et al (1982) The Evans syndrome: characterization of the responsible autoantibodies. Br J Haematol 51: 445\u2013450","journal-title":"Br J Haematol"},{"key":"2250_CR38","unstructured":"Petz LD, Garraty G (2004) Immune hemolytic anemias. Churchill Livingstone, Philadelphia"},{"key":"2250_CR39","first-page":"251","volume":"13","author":"Pirofsky","year":"1976","unstructured":"Pirofsky B (1976) Clinical aspects of autoimmune hemolytic anemia. Semin Hematol 13: 251\u2013265","journal-title":"Semin Hematol"},{"key":"2250_CR40","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","volume":"97","author":"Portielje","year":"2001","unstructured":"Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97: 2549\u20132554","journal-title":"Blood"},{"key":"2250_CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1423-0410.2008.01092.x","volume":"95","author":"Reil","year":"2008","unstructured":"Reil A, Keller-Stanislawski B, G\u00fcnay S, Bux J (2008) Specificities of leukocyte alloantibodies in transfusion-related acute lung injury and results of leukocyte antibody screening of blood donors. Vox Sang 95: 313\u2013317","journal-title":"Vox Sang"},{"key":"2250_CR42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2006.06436.x","volume":"136","author":"Roberts","year":"2007","unstructured":"Roberts L, Lucas G, Green L et al (2007) Autoimmune neutropenia following therapy for chronic lymphocytic leukaemia: a report of three cases. Br J Haematol 136: 348\u2013349","journal-title":"Br J Haematol"},{"key":"2250_CR43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1160\/TH08-06-0418","volume":"100","author":"Salama","year":"2008","unstructured":"Salama A, Kiesewetter H, Kalus U et al. (2008) Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia. Thromb Haemost 100: 762\u2013765","journal-title":"Thromb Haemost"},{"key":"2250_CR44","first-page":"54","volume":"29","author":"Salama","year":"1992","unstructured":"Salama A, Mueller-Eckhardt C (1992) Immune-mediated blood cell dyscrasias related to drugs. Semin Hematol 29: 54\u201363","journal-title":"Semin Hematol"},{"key":"2250_CR45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0140-6736(83)90175-7","volume":"2","author":"Salama","year":"1983","unstructured":"Salama A, Mueller-Eckhardt C, Kiefel V (1983) Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 2: 193\u2013195","journal-title":"Lancet"},{"key":"2250_CR46","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.1538-7836.2006.02147.x","volume":"4","author":"Segal","year":"2006","unstructured":"Segal JB, Powe NR (2006) Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 4: 2377\u20132383","journal-title":"J Thromb Haemost"},{"key":"2250_CR47","first-page":"753","volume":"46","author":"Selleng","year":"2006","unstructured":"Selleng K, Greinacher A (2006) Medikamenten-induzierte Thrombozytopenie. Intern Praxis 46: 753\u2013765","journal-title":"Intern Praxis"},{"key":"2250_CR48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1054\/blre.2001.0172","volume":"16","author":"Semple","year":"2002","unstructured":"Semple JW (2002) Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev 16: 9\u201312","journal-title":"Blood Rev"},{"key":"2250_CR49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00062752-200105000-00007","volume":"8","author":"Smith","year":"2001","unstructured":"Smith MA, Smith JG (2001) The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia. Curr Opin Hematol 8: 165\u2013169","journal-title":"Curr Opin Hematol"},{"key":"2250_CR50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/shem.2002.31918","volume":"39","author":"Starkebaum","year":"2002","unstructured":"Starkebaum G (2002) Chronic neutropenia associated with autoimmune disease. Semin Hematol 39: 121\u2013127","journal-title":"Semin Hematol"},{"key":"2250_CR51","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","volume":"98","author":"Stasi","year":"1995","unstructured":"Stasi R, Stipa E, Masi M et al (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 98: 436\u2013442","journal-title":"Am J Med"},{"key":"2250_CR52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0887-7963(93)70146-7","volume":"7","author":"Stroncek","year":"1993","unstructured":"Stroncek DF (1993) Drug-induced immune neutropenia. Transfus Med Rev 7: 268\u2013274","journal-title":"Transfus Med Rev"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-008-2250-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2250-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:49:59Z","timestamp":1589582999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-008-2250-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,20]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["2250"],"URL":"https:\/\/doi.org\/10.1007\/s00108-008-2250-5","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,20]]}}}